$0.77 EPS Expected for General Mills, Inc. (GIS); Shorts at Nanoviricides New (NYSEAMERICAN:NNVC) Lowered By 12.98%

February 23, 2018 - By Winifred Garcia

Analysts expect General Mills, Inc. (NYSE:GIS) to report $0.77 EPS on March, 20.They anticipate $0.05 EPS change or 6.94% from last quarter’s $0.72 EPS. GIS’s profit would be $438.16 million giving it 17.84 P/E if the $0.77 EPS is correct. After having $0.82 EPS previously, General Mills, Inc.’s analysts see -6.10% EPS growth. The stock increased 0.86% or $0.47 during the last trading session, reaching $54.95. About 3.59 million shares traded. General Mills, Inc. (NYSE:GIS) has declined 10.63% since February 23, 2017 and is downtrending. It has underperformed by 27.33% the S&P500.

Nanoviricides Inc New (NYSEAMERICAN:NNVC) had a decrease of 12.98% in short interest. NNVC’s SI was 356,700 shares in February as released by FINRA. Its down 12.98% from 409,900 shares previously. With 161,500 avg volume, 2 days are for Nanoviricides Inc New (NYSEAMERICAN:NNVC)’s short sellers to cover NNVC’s short positions. The SI to Nanoviricides Inc New’s float is 0.79%. It closed at $0.96 lastly. It is down 13.42% since February 23, 2017 and is downtrending. It has underperformed by 30.12% the S&P500.




NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company has market cap of $60.80 million. The firm is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus drug candidate that could enable a functional cure for HIV/AIDS. It currently has negative earnings. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses.

Investors sentiment decreased to 1.22 in Q3 2017. Its down 1.18, from 2.4 in 2017Q2. It dived, as 5 investors sold NanoViricides, Inc. shares while 4 reduced holdings. 7 funds opened positions while 4 raised stakes. 3.64 million shares or 0.08% more from 3.63 million shares in 2017Q2 were reported. Sei Investments has 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 7,202 shares. Rnc Cap Management Ltd Liability Com reported 15,143 shares. Scotia Cap reported 0% stake. Morgan Stanley stated it has 0% in NanoViricides, Inc. (NYSEAMERICAN:NNVC). Bartlett & Limited Liability holds 0% of its portfolio in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 40,714 shares. Pioneer Tru Bancorp N A Or stated it has 100,000 shares or 0.06% of all its holdings. 2,957 were reported by Royal Bank & Trust Of Canada. Goldman Sachs Gp Incorporated holds 0% or 12,883 shares. Bancorp Of Montreal Can holds 0% or 2,857 shares. Virtu Fincl Ltd Com holds 33,663 shares or 0% of its portfolio. Northern Corp invested in 95,158 shares or 0% of the stock. Bridgeway Capital Management invested in 0% or 268,000 shares. Wells Fargo & Mn reported 0% stake. Pittenger And Anderson owns 0% invested in NanoViricides, Inc. (NYSEAMERICAN:NNVC) for 300 shares. Renaissance Techs Ltd holds 0% or 485,000 shares.

Since January 9, 2018, it had 0 buys, and 1 insider sale for $517,458 activity. Shares for $517,458 were sold by Quam Bethany C. on Tuesday, January 9.

General Mills, Inc. manufactures and markets branded consumer foods in the United States. The company has market cap of $31.27 billion. The firm operates in four divisions: North America Retail; Convenience Stores & Foodservice; Europe & Australia; and Asia & Latin America. It has a 20.15 P/E ratio. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, frozen pizza and pizza snacks, shelf stable and frozen vegetables, and ice cream and frozen desserts, as well as grain, fruit and savory snacks; and various organic products, including nutrition bars, meal kits, salty snacks, and ready-to-eat cereal.

Among 23 analysts covering General Mills Inc. (NYSE:GIS), 3 have Buy rating, 4 Sell and 16 Hold. Therefore 13% are positive. General Mills Inc. had 68 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Equalweight” rating and $66 target in Thursday, July 14 report. Morgan Stanley maintained General Mills, Inc. (NYSE:GIS) rating on Thursday, September 21. Morgan Stanley has “Equal-Weight” rating and $52 target. UBS maintained General Mills, Inc. (NYSE:GIS) on Thursday, September 22 with “Neutral” rating. Credit Suisse maintained General Mills, Inc. (NYSE:GIS) on Thursday, December 21 with “Hold” rating. The stock of General Mills, Inc. (NYSE:GIS) has “Hold” rating given on Wednesday, February 15 by Deutsche Bank. The stock of General Mills, Inc. (NYSE:GIS) has “Hold” rating given on Monday, October 23 by RBC Capital Markets. RBC Capital Markets maintained it with “Sector Perform” rating and $58 target in Thursday, September 21 report. The company was maintained on Thursday, September 21 by Bank of America. The stock of General Mills, Inc. (NYSE:GIS) earned “Neutral” rating by Susquehanna on Monday, October 26. The firm has “Buy” rating given on Monday, December 18 by Wells Fargo.

Investors sentiment decreased to 0.84 in 2017 Q3. Its down 0.16, from 1 in 2017Q2. It is negative, as 81 investors sold General Mills, Inc. shares while 366 reduced holdings. 62 funds opened positions while 314 raised stakes. 401.33 million shares or 2.97% more from 389.74 million shares in 2017Q2 were reported. Live Your Vision Limited Company holds 0% in General Mills, Inc. (NYSE:GIS) or 100 shares. Plancorp holds 0.12% of its portfolio in General Mills, Inc. (NYSE:GIS) for 7,684 shares. Reliant Inv Ltd Limited Liability Company reported 4,000 shares. Dana Advsr stated it has 0.34% of its portfolio in General Mills, Inc. (NYSE:GIS). 43,040 are held by Iowa Bancorp. Goldman Sachs Gp has 3.50M shares for 0.04% of their portfolio. Everence Capital Management holds 23,656 shares or 0.28% of its portfolio. Manufacturers Life Insurance The reported 0.04% of its portfolio in General Mills, Inc. (NYSE:GIS). Holderness holds 0.24% or 9,097 shares. Finemark Bancorporation And Trust reported 0.13% stake. Monroe Bank & Trust Mi holds 0.29% or 13,517 shares. Leavell Invest holds 4,620 shares. Pinebridge Invests Lp invested 0.42% in General Mills, Inc. (NYSE:GIS). Steinberg Asset holds 0.04% or 5,810 shares. Oakworth owns 12,478 shares for 0.17% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: